medigraphic.com
ISSN 1561-3186 (Electronic)

2020, Number 3

<< Back Next >>

Rev Acta Médica 2020; 21 (3)

Radiotherapy in the Aged Adult at ''Vladimir Ilich Lenin'' Hospital

Tillán GA, Hernández OJ, Olivera FEM, Guevara AG, Torralbas FAL

Language: Spanish
References: 24
Page: 1-12
PDF size: 320.80 Kb.


ABSTRACT

Introduction: Cancer is considered a disease in the elderly. The risk for cancer increases with age due to a longer period of exposure to many carcinogens. In general, there is currently a tendency to limit cancer-specific treatment due to advanced age.
Objective: To determine the clinical-biological characteristics of aged adult patients treated with radiotherapy at Vladimir Ilich Lenin Hospital in the period from January to December 2015.
Methods: A retrospective descriptive study was carried out with 154 aged adult patients, carriers of the first five most frequent locations of cancer, who attended the radiotherapy consultation of Holguín Oncology Center in the period from January to December 2015. For the study, we used the theoretical methods of analysis and synthesis and descriptive statistics.
Results: We found that the most affected age group was that from 70 to 79 years (70.1% of the cases), with a predominance of males, accounting for 56.4% of the patients. Lung cancer was the most frequent tumor in men; and breast neoplasia, in women, accounting for 31% and 31.4%, respectively. 64.8% of the patients were diagnosed with stages II and III of the disease. 44.1% of the patients studied had a complete response to radiotherapy.
Conclusions: Radiotherapy is a basic pillar for treating the aged adult patient diagnosed with cancer. Age was not a factor that influenced response to treatment.


REFERENCES

  1. Cuba. Ministerio de Salud Pública. Instituto Nacional de Oncología y Radiología. Programa Nacional de Reducción de la Mortalidad por Cáncer. MINSAP. 2001.

  2. Alcina S, Barroso MC. Incidencia de Cáncer en la Tercera Edad en Cuba. Rev. Cubana Oncología. 2004;14(2):121-8.

  3. Gómez Pavón F, Ribera Casado J. Valoración Geriátrica de las Enfermedades Malignas. En: Pérez Molero A, ed. Clínica y Enfermería Geriátrica. Madrid: Síntesis. 1999;89-107.

  4. Soriano García L.J. y col. “El Cáncer en la Tercera Edad”. Rev. Cub. Oncología, enero-junio, 2004:30-8.

  5. Registro Nacional de Cáncer: INOR 2000-2005.

  6. Ped J.Incidence of malignant tumors in US older mans. Medical Advances 2001;86:254-8.

  7. Organización Panamericana de la Salud (1994); La atención a los ancianos: un desafío para los años noventa. Publicación científica No. 146, Washington.

  8. Caplin ME, Baudin E, Ferolla P, et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol. 2015 Aug; 26(8):1604-20.

  9. Ruoshi Shi, Nikolina Radulovich, Christine Ng, et al. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer. Clin Cancer Res. March 1 2020 26 (5) 1162-74; CCR-19-1376. Disponible en: https://doi.org/10.1158/1078-0432

  10. Barceló, A, Ramos, M. De la Iglesia, M., Zaforteza, M. Tratamiento del cáncer de próstata en función de la esperanza de vida, la comorbilidad y las guías de práctica clínica. An. Sist. Sanit. Navar.. (2014);37(3):339-48.

  11. Cakir, A., Akgun, Z., Fayda, M., Agaoglu, F. Comparison of Three Dimensional Conformal Radiation Therapy, Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Low Radiation Exposure of Normal Tissue in Patients with Prostate Cancer. Asian Pac J Cancer Prev. 2016;16(8):3365-70.

  12. Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017; 28:iv22-iv40.

  13. Rödel C, Graeven U, Fietkau R, et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. .Lancet Oncol. 2015;16:979-89.

  14. Zaborowski A, Stakelum A, Winter DC. Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer.Br J Surg. 2019;106:979-87.

  15. Carpinetti P, Donnard E, Bettoni F, et al. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neo-adjuvant chemoradiation. Oncotarget. 2015;6:38360-71.

  16. Melody Cobleigh, Denise A. Yardley, Adam M. Brufsky, et al. Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs. Clin Cancer Res. 2020; 26(5):1105-13. Disponible en: https://doi.org/10.1158/1078-0432.CCR-19-2350

  17. Kyriakos P. Papadopoulos, Melissa L. et al. First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies. Clin Cancer Res. 2020;26(5):1025-33. Disponible en: https://doi.org/10.1158/1078-0432.CCR-19-2609

  18. N. Colombo, C. Creutzberg, F. Amant, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up Ann Oncol. 2016 Jan;27(1):16-41.

  19. Senra L, Menéndez R. Identificación de tumor primario en pacientes con metástasis como forma de presentación de cáncer. Rev Cubana Med. 2014;53:402-16.

  20. Budach V, Stromberger C, Poettgen C, Baumann M, Budach W, Grabenbauer G, Marnitz S, Olze H, Wernecke K, Ghadjar P. Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial. Int J Radiat Oncol Biol Phys. 2015;91(5):916-24.

  21. Domínguez M, et al. Papel de la Radioterapia en el Siglo XXI. Navarra, España. 2009 [acceso: 09/02/2015] Disponible en: https://scielo.isciii.es/pdf/asisna/v32s2/original1.pdf

  22. Korsager, A., Carl, J., Riis Østergaard, L. Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancer. J Appl Clin Med Phys. 2016;17(3):6088.

  23. Inohara H, Takenaka Y, Yoshii T, Nakahara S, et al. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV. Squamous cell carcinoma of the head and neck. Int J Radiant Oncol Biol Phys. 2015;91(5):934-41.

  24. Shenouda G, Zhang Q, Ang KK, Machtay M, Parliament MB, et al. Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2015;91(5):907-15.




2020     |     www.medigraphic.com